Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up

NCT05893758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2024-08-30

No results posted yet for this study

Summary

The objective of this post-market registry is to assess the clinical use of the Lifetech Cera™ PFO Occluder in a real-world and on-label fashion.

Conditions

  • Patent Foramen Ovale
  • PFO

Interventions

DEVICE

The Cera™ PFO Occluder

The Cera™ PFO Occluder is a percutaneous, transcatheter closure device for the non-surgical closure of Patent Foramen Ovale (PFO).

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05893758 on ClinicalTrials.gov